Pharmaceutical composition of didanosine and application of pharmaceutical composition in biological medicines

A technology of didanosine and its composition, which is applied in the field of pharmaceutical composition and its application in biomedicine, and can solve the problems that have not yet been reported on the correlation between didanosine and its pharmaceutical composition and liver depression syndrome, To achieve the effect of improving the therapeutic effect

Inactive Publication Date: 2016-10-12
刘芊芊
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] So far, there has been no report on the correlation between dida

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition of didanosine and application of pharmaceutical composition in biological medicines
  • Pharmaceutical composition of didanosine and application of pharmaceutical composition in biological medicines
  • Pharmaceutical composition of didanosine and application of pharmaceutical composition in biological medicines

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0017] Example 1: Compound (Ⅰ) isolation preparation and structure confirmation

[0018] Separation method: (a) Crush the small bark bone (3kg), heat reflux with 75% ethanol for extraction (20L×3 times), combine the extracts, concentrate until there is no alcohol smell (4L), and use petroleum ether (4L×3). Times), ethyl acetate (4L×3 times) and water-saturated n-butanol (4L×3 times) to obtain petroleum ether extract, ethyl acetate extract and n-butanol extract respectively; (b) step ( a) The medium n-butanol extract is removed with AB-8 type macroporous resin, first eluted with 6% ethanol for 8 column volumes, and then eluted with 70% ethanol for 8 column volumes, collect 70% eluate, reduce Press and concentrate to obtain 70% ethanol elution concentrate; (c) In step (b), the 70% ethanol elution concentrate is separated with normal phase silica gel, and the volume ratio is 50:1 (8 column volumes), 25:1 (8 column volumes), 15:1 (8 column volumes) and 5:1 (10 column volumes) of dic...

Example Embodiment

[0021] Example 2: Pharmacological effects

[0022] In this example, a rat model of liver depression syndrome was prepared by gavage of thyroxine tablets and fed with hunger and satiety. It was observed that the drug reduced animal plasma serotonin (5-hydroxytryptamine, 5-HT), norepinephrine (norepinephrine, NE), Epinephrine (epinephrine, E) level and other aspects of anti-liver depression syndrome.

[0023] 1. Materials and methods

[0024] 1.1 Animals

[0025] Adolescent healthy female SD rats, weighing (200±10) g, and the animal feed is ordinary solid feed, all provided by the Experimental Animal Center of Medical College of Xi’an Jiaotong University, and they are raised, observed and researched in the Physiology Laboratory of Medical College of Xi’an Jiaotong University. Laboratory temperature (20±3)℃, humidity (55±5)℃, 12h lighting and ventilation.

[0026] 1.2 Reagents and samples

[0027] Didanosine was purchased from the National Institute for the Control of Pharmaceutical and B...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a didanosine pharmaceutical composition and its application in biomedicine. The didanosine pharmaceutical composition provided by the invention contains didanosine and a novel structure natural product compound (I ), when didanosine and compound (I) act alone, it has a therapeutic effect on liver stagnation syndrome; when didanosine and compound (I) act in combination, the therapeutic effect on liver stagnation syndrome is significantly improved, and can be developed into a therapeutic Compared with the prior art, the medicine for liver depression syndrome has outstanding substantive characteristics and remarkable progress.

Description

technical field [0001] The invention belongs to the field of biomedicine and relates to a new application of didanosine, in particular to a pharmaceutical composition of didanosine and its application in biomedicine. Background technique [0002] Didanosine inhibits HIV replication. Under the action of cellular enzymes, it is transformed into the metabolite dideoxyadenosine triphosphate (ddATP), which has antiviral activity, and is an inhibitor of human immunodeficiency virus (HIV) replication. Its mechanism of action is similar to that of zidovudine. [0003] So far, there has been no report on the correlation between didanosine and its pharmaceutical composition and liver stagnation syndrome. Contents of the invention [0004] The object of the present invention is to provide a pharmaceutical composition of didanosine, which contains didanosine and a natural product with a novel structure, and didanosine and the natural product can synergistically treat liver depressio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07C69/73C07C67/48C07C67/54C07C67/56C07C67/58A61K31/22A61K31/708A61P1/16
CPCC07C69/73A61K31/22A61K31/708C07C67/48C07C67/54C07C67/56C07C67/58
Inventor 刘芊芊
Owner 刘芊芊
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products